| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Aspen Neuroscience, Inc.
13G
044933109
|
6.7% |
11/3/2026
Event 10/30/2026
|
|||
|
Global Business Travel Group, Inc.
13D/A
Amendment 3
GBTG · 37890B100
|
0% |
9/29/2026
Event 9/29/2026
|
|||
|
Nanobiotix SA
13G/A
Amendment 1
NBTX · 63009J107
|
7.0% |
7/29/2026
Event 6/30/2026
|
|||
| West Bay BDC LLC 13D/A Amendment 8 | 97.1% |
7/29/2026
Event 7/27/2026
|
|||
|
Global Business Travel Group, Inc.
13D/A
Amendment 2
GBTG · 37890B100
|
16.8% |
6/29/2026
Event 6/27/2026
|
|||
| West Bay BDC LLC 13D/A Amendment 7 | 97.1% |
6/8/2026
Event 6/4/2026
|
|||
|
Fluence Energy, Inc.
13G/A
Amendment 2
FLNC · 34379V103
|
8.3% |
5/19/2026
Event 5/15/2026
|
|||
|
Fluence Energy, Inc.
13D/A
Amendment 1
FLNC · 34379V103
|
8.9% |
5/19/2026
Event 5/15/2026
|
|||
|
Fluence Energy, Inc.
13D
FLNC · 34379V103
|
8.9% |
5/18/2026
Event 5/15/2026
|
|||
| 5C Lending Partners Corp. 13D | 17.7% |
5/13/2026
Event 3/20/2026
|
|||
|
Sionna Therapeutics Inc
13G/A
Amendment 1
SION · 829401108
|
4.5% |
5/12/2026
Event 3/31/2026
|
|||
| Qatar Investment Authority | 4.5% | ||||
| Q Healthcare Holding LLC | 4.5% | ||||
|
Global Business Travel Group, Inc.
13D/A
Amendment 1
GBTG · 37890B100
|
16.7% |
5/4/2026
Event 5/3/2026
|
|||
|
BioXcel Therapeutics, Inc.
13G/A
Amendment 1
BTAI · 09075P105
|
0.6% |
3/30/2026
Event 12/31/2025
|
|||
| West Bay BDC LLC 13D/A Amendment 6 | 97.1% |
2/25/2026
Event 2/23/2026
|
|||
|
Perspective Therapeutics Inc
13G
CATX · 46489V302
|
6.2% |
2/5/2026
Event 2/4/2026
|
|||
| West Bay BDC LLC 13D/A Amendment 5 | 97.1% |
12/11/2025
Event 12/10/2025
|
|||
| West Bay BDC LLC 13D/A Amendment 4 | 97.1% |
11/20/2025
Event 11/18/2025
|
|||
|
Global Business Travel Group, Inc.
13D
GBTG · 37890B100
|
16.6% |
10/2/2025
Event 9/9/2025
|
|||
|
Alignment Healthcare, Inc.
13G
ALHC · 01625V104
|
6.7% |
9/24/2025
Event 9/17/2025
|
|||
| Qatar Investment Authority | 6.7% | ||||
| Q Healthcare Holding LLC | 6.7% | ||||
| West Bay BDC LLC 13D/A Amendment 3 | 97.1% |
9/16/2025
Event 9/11/2025
|
|||
|
Vistra Corp
13G
VST · 92840M102
|
5.5% |
8/5/2025
Event 6/30/2025
|
|||
| Qatar Investment Authority | 5.5% | ||||
| Seismic Holding LLC | 5.5% | ||||
|
Sionna Therapeutics Inc
13G
SION · 829401108
|
5.0% |
6/16/2025
Event 6/11/2025
|
|||
| Qatar Investment Authority | 5.0% | ||||
| Q Healthcare Holding LLC | 5.0% | ||||
|
Establishment Labs Holdings Inc
13G/A
Amendment 1
ESTA · G31249108
|
8.3% |
5/13/2025
Event 3/31/2025
|
|||
|
Lomond Therapeutics Holdings, Inc.
13G
54173L101
|
7.8% |
3/26/2025
Event 3/24/2025
|
|||
| West Bay BDC LLC 13D/A Amendment 2 | 97.1% |
3/14/2025
Event 3/12/2025
|
|||
|
BioXcel Therapeutics, Inc.
13G
BTAI · 09075P105
|
5.2% |
12/18/2024
Event 11/25/2024
|
|||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.